Ann: Quarterly Shareholder Report, page-11

  1. 416 Posts.
    lightbulb Created with Sketch. 271
    On the last page in the section "About Syntara" it says that SNT-4728 is being "studied" in collaboration with Parkinson's UK. Although the word "studied" is deployed I had understood that a clinical trial in this indication is underway. Is this correct?

    It also says regarding SNT-5505 that protocols for another two phase 1c/2 studies with SNT-5505 in patients with a blood cancer called myelodysplastic syndrome are in development and expected to commence recruitment by H1 2025. This suggests that two new clinical trials using SNT-5505 will commence this half year. Is this new news? Is this interpretation correct?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.7¢
Change
0.000(0.00%)
Mkt cap ! $92.76M
Open High Low Value Volume
5.7¢ 5.8¢ 5.6¢ $57.98K 1.029M

Buyers (Bids)

No. Vol. Price($)
5 493270 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 102824 1
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.